Regeneron Pharmaceuticals, Inc. (REGN)
-NasdaqGS 248.83 
11.54(4.86%) 3:35PM EDT - Nasdaq Real Time Price
| Prev Close: | 237.29 |
|---|
| Open: | 242.98 |
|---|
| Bid: | 247.54 x 200 |
|---|
| Ask: | 247.67 x 200 |
|---|
| 1y Target Est: | 192.47 |
|---|
| Beta: | 0.84 |
|---|
| Next Earnings Date: | 3-May-13 |
|---|
| Day's Range: | 237.96 - 249.49 |
|---|
| 52wk Range: | 107.31 - 252.35 |
|---|
| Volume: | 1,593,253 |
|---|
| Avg Vol (3m): | 1,091,490 |
|---|
| Market Cap: | 23.93B |
|---|
| P/E (ttm): | 36.66 |
|---|
| EPS (ttm): | 6.76 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Regeneron Earnings Expected To Keep Boomingat Investor's Business Daily(Thu 1:21PM EDT)
- Analyst Moves: REGN, AGN, STXat Forbes(Thu 11:31AM EDT)
- Regeneron Pharmaceuticals Earnings Preview: Can This Streak Continue?at Wall St. Cheat Sheet(Thu 10:22AM EDT)
- Analysts' Actions: BEN CNX EXC REGN STXTheStreet(Thu 8:50AM EDT)
- 3 Healthcare Stock Stories For Midweek Wellnessat Wall St. Cheat Sheet(Thu 8:34AM EDT)
- Regeneron upgraded to Outperform from Market Perform at JMP Securitiestheflyonthewall.com(Thu 6:33AM EDT)
- Cramer's Top Stock Picks: AVT TKR AGN REGNat TheStreet(Thu 6:00AM EDT)
- Why Allergan's Pain Is Regeneron's Gainat Motley Fool(Wed, May 1)
- [video] Cramer's Thoughts on Wednesday's Declineat CNBC(Wed, May 1)
- After the close: Allergan losses worsen, Humana gains on earningsat MarketWatch(Wed, May 1)
- On The Fly: Closing Wrapat theflyonthewall.com(Wed, May 1)
- Forbes Earnings Preview: Regeneron Pharmaceuticalsat Forbes(Wed, May 1)
- Allergan Shares Fall After CEO Says Two Studies Delayedat Bloomberg(Wed, May 1)
- Stocks Pull Back In Higher Turnover, But Regeneron Soarsat Investor's Business Daily(Wed, May 1)
- [video] Tough Day for Stocksat CNBC(Wed, May 1)
Key Statistics
| Forward P/E (1 yr): | 39.68 |
|---|
| P/S (ttm): | 16.64 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 4.40 |
|---|
| Quarterly EPS Est
(Mar-13)
: | 0.95 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.58 |
|---|
Business Summary
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally.
View More